1227165-38-9

Basic information

• Product Name: 5-(4-fluoro-benzyl)-2-methyl-7-phenyl-5H-pyrazolo[1,5-d][1,2,4]triazin-4-one
• Synonyms: 5-(4-fluoro-benzyl)-2-methyl-7-phenyl-5H-pyrazolo[1,5-d][1,2,4]triazin-4-one
• CAS NO: 1227165-38-9
• Molecular Weight: 334.353
• Mol File: 1227165-38-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 5-(4-fluoro-benzyl)-2-methyl-7-phenyl-5H-pyrazolo[1,5-d][1,2,4]triazin-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(4-fluoro-benzyl)-2-methyl-7-phenyl-5H-pyrazolo[1,5-d][1,2,4]triazin-4-one(1227165-38-9)
• EPA Substance Registry System: 5-(4-fluoro-benzyl)-2-methyl-7-phenyl-5H-pyrazolo[1,5-d][1,2,4]triazin-4-one(1227165-38-9)

Safety Data

• Hazardous Substances Data: 1227165-38-9(Hazardous Substances Data)

Upstream product

• 1170502-60-9 2-methyl-7-phenyl-5H-pyrazolo[1,5-d] [1,2,4]triazin-4-one 
• 459-46-1 4-Fluorobenzyl bromide 
• 40535-14-6 3-methyl-1H-pyrazole-5-carbohydrazide 
• 4027-57-0 ethyl 5-methyl-2H-pyrazole-3-carboxylate 

Relevant articles and documents

SUBSTITUTED AZA-BRIDGED BICYCLICS FOR CARDIOVASCULAR AND CNS DISEASE

The invention relates to substituted imidazopyridines, pyrazolotriazinones, triazolopyridines, pyrazolopyridines and pyrazolopyrimidines that are useful for treating stroke, myocardial infarct, and cardiovascular inflammatory conditions, to pharmaceutical compositions comprising these compounds, and to methods for the treatment of stroke, myocardial infarct, and cardiovascular inflammatory conditions in a mammal. The compounds have general formula I (I) or II (II) in which Cy1 and Cy2 are carbocycles or heterocycles.